SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-014483
Filing Date
2018-10-15
Accepted
2018-10-15 16:41:56
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 939779
2 ex31-1.htm EX-31.1 19254
3 ex31-2.htm EX-31.2 18102
4 ex32-1.htm EX-32.1 7475
5 ex32-2.htm EX-32.2 7661
  Complete submission text file 0001493152-18-014483.txt   5594437

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rspi-20180630.xml EX-101.INS 1085057
7 XBRL SCHEMA FILE rspi-20180630.xsd EX-101.SCH 66154
8 XBRL CALCULATION FILE rspi-20180630_cal.xml EX-101.CAL 41496
9 XBRL DEFINITION FILE rspi-20180630_def.xml EX-101.DEF 267220
10 XBRL LABEL FILE rspi-20180630_lab.xml EX-101.LAB 430078
11 XBRL PRESENTATION FILE rspi-20180630_pre.xml EX-101.PRE 329986
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 181122626
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1